Marian University, St. Vincent Health and four amateur sports groups have entered into formal discussions that could result in major developments at the northwest-side campus, the university announced Tuesday.
Just three months before the parent company of AIT Laboratories was sold in 2009 to its employees for $90 million, it was appraised for $17.1 million, according to a U.S. Department of Labor lawsuit.
The question of what constitutes a conflict of interest and why it matters for public officials has run throughout a string of high-profile ethics scandals in Indiana recently.
Takeda Pharmaceutical Co. and Eli Lilly and Co. lost a bid to have a judge throw out a combined $9 billion punitive-damage award over claims the drugmakers hid the cancer risks of their Actos diabetes medicine.
The Indiana Blood Center is set to lose more than one-third of its revenue early next year, as three hospital systems bolt for cheaper prices offered by the American Red Cross.
Franciscan Alliance, which operates three hospitals in the Indianapolis area, is seeing fewer patients this year but is making more money due to expense cuts.
Dr. William VanNess said Friday he plans to stay on the job until Gov. Pence finds a replacement, saying he likely will stay on until early October.
Mainstreet Property Group, already the fastest-growing company in the Indianapolis area, now has the fuel it needs to nearly triple its pace of construction of senior care facilities around the country.
Rural/Metro Corp. says the changing health care landscape and the challenges of covering rural communities are forcing it to end its area ambulance services. It’s also closing a billing operations center in Indianapolis.
Final approval could be delayed until mid-2016 due to a claim of patent infringement by drugmaker Sanofi.
A subsidiary of Dublin, Ohio-based Cardinal Health Inc. is seeking tax breaks from the city of Indianapolis to help it open a $14.4 million local drug-production facility that would employ 85 workers by 2017.
Rural/Metro Corp. is going to stop serving more than 30 communities in Indiana. Martinsville Mayor Phil Deckard said the company will end service within 60 days.
The rising threat from drug-resistant germs and increasing calls from global health groups for more potent antibiotics is placing a premium on companies such as Cubist. The $4.8 billion drug developer is preparing to introduce four new medicines by 2020.
Regenstrief, a not-for-profit medical research organization, plans to move 50 investigators, 165 staff members and a number of affiliated scientists into the building when it is completed in mid-2015.
The plant closure will affect 23 plant employees, all of whom will be offered comparable positions at a Lilly plant near Clinton that employs about 500 workers.
U.S. District Judge William T. Lawrence in Indianapolis on Tuesday denied an IRS bid to dismiss that portion of the state’s 2013 lawsuit, in which it claimed the rule illegally conflicts with a provision of the federal law.
The name change will be completed by the end of the year, pending shareholder approval, the company said Tuesday.
Bloomington’s Monroe Hospital, which has had a close relationship with Indianapolis-based St. Vincent Health, filed for bankruptcy reorganization on Friday and plans to sell its business to a Canadian operator.
Tens of thousands of military veterans who have been enduring long waits for medical care should be able to turn to private doctors almost immediately under a law signed Thursday.
Founders of Chondrial Therapeutics believe that if further testing validates their treatment for Friedreich’s ataxia, it could be a blockbuster with annual sales topping $1 billion.
